General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Couto JP et al. - Authors summarize most of the molecular alterations that are currently used as targets for the new biological treatments and anticipate some of the changes that are already occurring or will occur in the therapy of patients with thyroid cancer.

Related Articles

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09    Relevance Score: 71%

Diffuse Sclerosing Variant Is a Major Subtype of Papillary Thyroid Carcinoma in the Young
Thyroid, 11/06/09    Relevance Score: 70%

Geographical correlation between incidence of benign disease and that of cancer of the thyroid among the population of the Rhone-Alpes region of France
European Journal of Endocrinology, 10/14/09    Relevance Score: 69%

Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study
Journal of Clinical Endocrinology and Metabolism, 11/12/09    Relevance Score: 68%

Thyroid cancer a risk after childhood cancer
Reuters, 10/28/09    Relevance Score: 68%

Today in Endocrine...keeping you current

Superficial selective cervical plexus block following total thyroidectomy: A randomized trial
Head & Neck, 12/02/09

Surgical management of tracheal shaving for papillary thyroid carcinoma with tracheal invasion
Acta Oto-Laryngologica , 12/01/09

Minimally Invasive Parathyroidectomy
Archives of Otolaryngology, 11/30/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address